Marina Biotech Inc (NASDAQ:MRNA) escalated 10.58% to $1.16. Debiopharm Group and Marina Biotech have entered into an exclusive agreement concerning the development and commercialization of Marina Biotech's pre-clinical program in bladder cancer.
The New York Times Company (NYSE:NYT) declined 5.03% to $10.18 after the Company posted fourth quarter results. Total revenues decreased 2.9% in the fourth quarter of 2010. Earnings per share from continuing operations were $.44 per share compared to $.48 in the fourth quarter of 2009.
BMC Software Inc (NASDAQ:BMC) increased 0.44% to $48.41 after Credit Suisse increased the price target from $52.00 to $55.00. They have maintained an outperform rating on the stock.
Article published by Wall Street Grand. Visit the Wall Street Grand Club today. Disclaimer: For our full disclosure please visit - http://www.wallstreetgrand.com/disclosure.html
